Toggle light / dark theme

Surprise patent ruling revives high-stakes dispute over the genome editor CRISPR

U.S. patent officials reexamining claims about who deserves rights to enormously valuable aspect of the invention.

Leave a Comment

If you are already a member, you can use this form to update your payment info.

Lifeboat Foundation respects your privacy! Your email address will not be published.